Feedback Techniques to Target Functional Deficits Following Anterior Cruciate Ligament Reconstruction: Implications for Motor Control and Reduction of Second Injury Risk

Alli Gokeler; Anne Benjaminse; Timothy E. Hewett; Mark V. Paterno; Kevin R. Ford

doi:10.1007/s40279-013-0095-0

Home SearchPaper Details

Feedback Techniques to Target Functional Deficits Following Anterior Cruciate Ligament Reconstruction: Implications for Motor Control and Reduction of Second Injury Risk

Alli Gokeler, Anne Benjaminse, Timothy E. Hewett, Mark V. Paterno, Kevin R. Ford, Egbert Otten, Gregory D. Myer

Springer Science+Business Media (2013) • Volume 43, Issue 11, Pages 1065-1074

PDF Available

Quick Actions

Read Full Paper

Publication Info

DOI

10.1007/s40279-013-0095-0

Language

English

Topic

Knee injuries and reconstruction techniques

Keywords

Rehabilitation, Physical medicine and rehabilitation, Sports medicine, Anterior cruciate ligament, Anterior cruciate ligament reconstruction, Medicine, Motor learning, ACL injury, Physical therapy, Injury prevention, Poison control, Psychology, Surgery, Medical emergency, Neuroscience

Published

September 23, 2013

Citations

108 citations

FWCI

6.33

External Resources

DOI Link OpenAlex

Feedback Techniques to Target Functional Deficits Following Anterior Cruciate Ligament Reconstruction: Implications for Motor Control and Reduction of Second Injury Risk

Quick Actions

Publication Info

External Resources

Suggested Papers

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Students’ voices on generative AI: perceptions, benefits, and challenges in higher education

Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma

Suggested Papers

Suggested Papers

Revolutionizing healthcare: the role of artificial intelligence in clinical practice

Students’ voices on generative AI: perceptions, benefits, and challenges in higher education

Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma